Shionogi & Co.,Ltd. Logo

Shionogi & Co.,Ltd.

4507 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町3丁目1番8号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Shionogi & Co., Ltd. is a prominent Japanese pharmaceutical company with a rich history spanning over 140 years. Committed to improving the health and well-being of patients globally, Shionogi focuses on innovative drug development and the delivery of transformative therapies. The company prides itself on its passionate workforce, which embodies a longstanding commitment to societal needs and environmental sustainability. By leveraging extensive research and development capabilities, Shionogi aims to address critical healthcare challenges while fostering a healthier planet. As a forward-thinking organization, Shionogi continues to advance its mission of serving patients, society, and the environment through dedicated efforts and sustainable practices.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Shionogi & Co.,Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-19 09:24
Regulatory News Service
臨時報告書
Japanese 30.7 KB
2025-06-19 09:14
Regulatory News Service
内部統制報告書-第160期(2024/04/01-2025/03/31)
Japanese 30.2 KB
2025-06-19 09:12
Regulatory News Service
確認書
Japanese 8.9 KB
2025-06-19 09:10
Annual Report
有価証券報告書-第160期(2024/04/01-2025/03/31)
Japanese 2.5 MB
2025-06-19 08:07
Regulatory News Service
公開買付報告書
Japanese 41.6 KB
2025-06-19 06:40
Major Shareholding Notification
大量保有報告書
Japanese 61.0 KB
2025-06-18 08:49
Regulatory News Service
臨時報告書
Japanese 41.9 KB
2025-06-04 08:39
Regulatory News Service
訂正公開買付届出書
Japanese 258.4 KB
2025-05-28 08:38
Regulatory News Service
訂正公開買付届出書
Japanese 262.0 KB
2025-05-08 05:52
Regulatory News Service
公開買付届出書
Japanese 530.2 KB
2025-05-07 09:12
Regulatory News Service
臨時報告書
Japanese 50.3 KB
2024-11-08 02:44
Regulatory News Service
確認書
Japanese 9.0 KB
2024-11-08 02:41
Interim Report
半期報告書-第160期(2024/04/01-2025/03/31)
Japanese 320.3 KB
2024-06-21 08:18
Regulatory News Service
臨時報告書
Japanese 27.6 KB
2024-06-21 04:28
Regulatory News Service
内部統制報告書-第159期(2023/04/01-2024/03/31)
Japanese 24.1 KB

Automate Your Workflow. Get a real-time feed of all Shionogi & Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Shionogi & Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK